Amalgamated Bank Fate Therapeutics Inc Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Amalgamated Bank holds 2,912 shares of FATE stock, worth $6,668. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,912

Previous 2,912 -0.0%

Holding current value

$6,668

Previous $10,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$3.54 - $8.35 $16,053 - $37,867	-4,535 Reduced 60.9%	2,912 $21,000
Q4 2023 Feb 06, 2024	SELL	$1.65 - $3.94 $1,430 - $3,415	-867 Reduced 10.43%	7,447 $28,000
Q2 2023 Aug 11, 2023	SELL	$4.76 - $6.59 $15,803 - $21,878	-3,320 Reduced 28.54%	8,314 $39,000
Q1 2023 May 02, 2023	SELL	$4.24 - $11.12 $7,394 - $19,393	-1,744 Reduced 13.04%	11,634 $66,000
Q3 2022 Nov 09, 2022	BUY	$21.04 - $36.06 $4,523 - $7,752	215 Added 1.63%	13,378 $300,000
Q2 2022 Aug 15, 2022	SELL	$17.78 - $42.39 $2,186 - $5,213	-123 Reduced 0.93%	13,163 $326,000
Q1 2022 Jun 30, 2022	SELL	$29.67 - $60.28 $29,610 - $60,159	-998 Reduced 6.99%	13,286 $515,000
Q4 2021 Feb 15, 2022	SELL	$47.84 - $64.34 $7,271 - $9,779	-152 Reduced 1.05%	14,284 $836,000
Q3 2021 Oct 29, 2021	SELL	$59.27 - $95.73 $41,785 - $67,489	-705 Reduced 4.66%	14,436 $856,000
Q2 2021 Aug 16, 2021	BUY	$67.25 - $92.52 $289,175 - $397,836	4,300 Added 39.66%	15,141 $1.31 Million
Q1 2021 May 13, 2021	SELL	$72.16 - $117.4 $25,544 - $41,559	-354 Reduced 3.16%	10,841 $894,000
Q4 2020 Feb 12, 2021	BUY	$38.09 - $100.95 $2,056 - $5,451	54 Added 0.48%	11,195 $1.02 Million
Q3 2020 Oct 30, 2020	BUY	$30.41 - $40.5 $33,937 - $45,198	1,116 Added 11.13%	11,141 $445,000
Q2 2020 Aug 10, 2020	SELL	$20.21 - $35.23 $19,401 - $33,820	-960 Reduced 8.74%	10,025 $344,000
Q1 2020 May 13, 2020	SELL	$17.28 - $31.88 $11,543 - $21,295	-668 Reduced 5.73%	10,985 $244,000
Q4 2019 Feb 13, 2020	BUY	$13.39 - $20.73 $156,033 - $241,566	11,653 New	11,653 $228,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $222M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Fate Therapeutics Inc Transaction History